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Abstract 
Two new alkaloids, poggeicridone (1) and 2-methoxy-7,8- dehydroruteacarpine (6), together 
with nine known compounds, were isolated from the dichloromethane (DCM) extract of the 
bark of Zanthoxylum poggei (Engl.) P. G. Waterman. The structures of all compounds were 
determined by comprehensive spectroscopic analyses (1D and 2D NMR and EI- and ESI-MS)). 
Compounds 5-9 exhibited strong suppressive effects on the phagocytosis response upon 
activation with serum opsonized zymosan in the in vitro oxidative burst studies using whole 
blood. The IC50 values were in the range of 12.0-25.9 μM. These compounds displayed a 
moderate level of cytotoxic activity against the human Caucasian prostate adenocarcinoma cell 
line PC-3, with IC50 values of 15.8 and 22.1 µM (the IC50 value of the positive control standard 
doxorubicin was IC50 0.9 µM). All isolated compounds were also tested against plant 
pathogenic bacteria, fungi and oomycetes using the paper disk agar diffusion assay, resulting 
in no significant activities (MICs > 1 mg/mL). 
 
Keywords: Zanthoxylum pogeei; Rutaceae; acridone; indoloquinazoline alkaloids; oxidative 
burst inhibition; antimicrobial; cytotoxic activities.  
 
1. Introduction 
As part of our continuing research for bioactive molecules from Cameroonian plants, 
Zanthoxylum poggei (Engl.) P. G. Waterman (Rutaceae) (Syn. Fagara poggei Engl.) was 
studied as there has been no report on any phytochemical study on this species available to 
date. Z. poggei is a liane or scandent shrub of the African rainforests in countries including 
Cameroon and Congo. In a traditional medicine setting, it is used for the treatment of tumours, 
swellings, inflammation, malaria and gonorrhoea, as well as to prepare poisonous arrows 
(Irvine, 1961; Raponda-Walker and Sillans, 1961); the root bark of this plant is also used as a 
toothbrush (Kerharo and Adam, 1971). Previous phytochemical investigations on other species 
of the Zanthoxylum revealed the presence of acridones, amides, aporphines, 
bezophenanthridines, coumarins, fatty acids, flavonoids, indoloquinazolines, lignans, phenolic 
compounds, steroids and triterpenoids,  (Waterman, 1976; Tringali et al., 2001; Mbaze et al., 
2007; Mbaze et al., 2009; Wansi et al., 2009; Wouatsa et al., 2013, Wang et al., 2014) with 
some of these compounds exhibiting potent antibacterial, fungicidal and cytotoxic activity, as 
well as oxidative burst and -glucosidase inhibition and toxic properties (Tringali et al., 2001; 
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Ogwal-Okeng et al., 2003; Mbaze et al., 2007; Mbaze et al., 2009; Wansi et al., 2009; Wouatsa 
et al., 2013). In this report, we describe the isolation and structural elucidation of a novel dimer 
acridone-acridone alkaloid with C-O-C linkage, poggeicridone (1), and a new 
indoloquinazoline alkaloid, 2-methoxy-7,8-dehydroruteacarpine (6), together with the 
oxidative burst inhibition, cytotoxic evaluation and antimicrobial properties of isolated 
compounds. 
2. Results and discussion 
The stem bark of Z. poggei was extracted with CH2Cl2 and subjected to bioassay-guided 
fractionation based on its inhibitory activity against the oxidative burst of whole blood (90%). 
This extract was subjected to column chromatography (silica gel) and preparative TLC to 
afford two new and eleven known compounds (Fig. 1). By comparison with the reported data, 
the known compounds were identified as citracridone I (2), citracridone III (3), 5-
hydroxynoracronycine (4), 5-methoxynoracronycine (5), 2-hydroxyruteacarpine (7), 2-
methoxyruteacarpine (8), 5,8,13,14-tetrahydro-2-methoxy-14-méthyl-5-oxo-7H-
indolo[2’,3’:3,4]pyrido[2,1-b]quinazolin-6-ium chloride (9), lupeol and β-sitosterol (Ezugwu 
et al., 2003; Wansi et al., 2008, Happi et al., 2011; Fomani et al., 2016), whilst the new 
compounds were identified by comprehensive spectroscopic analyses. 
Compound 1 was obtained as a yellow amorphous powder, showing a positive reaction with 
FeCl3, indicating its phenolic nature. The pseudomoelcular ion was found to be C39H34O8N2Na 
by HR-ESIMS ([M+Na]+ at m/z 681.2209, calcd 681.2213). The UV spectrum showed a highly 
conjugated system with absorption bands characteristic of acridone-type alkaloids at λmax 265, 
295, 350 and 390 nm (Wu and Chen, 2000). The IR bands at max 3900, 3450 and 1640, 1631 
cm-1 inferred the presence of an OH and conjugated carbonyl groups. 
The 1H NMR spectrum (Table 1) exhibited two deshielded protons at δH 14.51 (1H, s) and 
14.55 (1H, s) exchangeable with D2O suggesting the presence of two acridone nuclei in 1 
(Takemura et al., 1998). In the aromatic region, an ABC system of three aromatic protons at 
δH 7.83 (dd, J = 7.5, 1.3 Hz); 7.24 (t, J = 7.5 Hz); 7.33 (dd, J = 7.5, 1.3 Hz) could be attributed 
to H-8’, H-7’ and H-6’, respectively. An AB system of two aromatic protons at δH 7.97 (d, J = 
8.8 Hz); 7.01 (d, J = 8.8 Hz) were assigned to H-8 and H-7, respectively. These assignments 
were determined through the lower-field signal of H-8 and H-8’, which was deshielded by the 
adjacent carbonyl group of the acridone moiety (Wansi et al., 2006). Furthermore, the 1H NMR 
spectrum showed two N-methyl group at δH 3.80 and 3.87, two aromatic protons as singlet at 
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δH 6.12 (H-2) and 6.13 (H-2’), one methoxy group at δH 3.90 and the presence of two 2,2-
dimethylpyran ring at δH 6.76 (1H, d, J = 9.7 Hz, H-11), 5.70 (1H, d, J = 9.7 Hz, H-12), 1,52 
(CH3-14) and 1,48 (CH3-15) and at δH 6.74 (1H, d, J = 9.8 Hz, H-11’), 5.68 (1H, d, J = 9.8 Hz, 
H-12’), 1,52 (CH3-14’) and 1,47 (CH3-15’). Thus, compound 1 was assumed to be a bis-
alkaloid of two acridone moieties. This inference was confirmed by the 13C NMR data (Table 
1), displaying characteristic signals of citracridone I and hydroxynoracronycine (Happi et al., 
2011), and also by 2D NMR analyses. 
 
The orientation of the two dimethylchroman rings was precisely determined by the HMBC 
analysis. In the HMBC spectrum, proton H-11 (δH 6.76) showed correlation with the carbon 
signals at C-4a (δC 147.6), C-3 (δC 161.2), C-4 (δC 102.5) and C-13 (δC 76.5) and on the other 
hand, H-11’ (δH 6.74) exhibited correlations to the carbon signals at C-3’ (δC 160.9), C-4a’ (δC 
147.9), C-4’ (δC 102.3) and C-13’ (δC 76.5). These findings confirmed that the two 
dimethylchromene rings were fused in an angular fashion to the acridone’s nucleus at positions 
C-3/C-4 and C-3’/C-4’. Therefore, establishing the linkage between the two nuclei was 
required. In the HMBC spectrum, the 4J correlation observed between proton H-6’ (δH 7.33) 
and carbon C-5 (δC 137.1) supported the position of the linkage between C5-O-C5’. The 
presence of C-O-C linkage was further supported by the EIMS, which showed two important 
ion fragments at m/z 363 (5-hydroxy-6-methoxynoracronycine, C20H28NO5) and at m/z 347 (5-
hydroxynoracronycine, C19H23NO5) resulting in the breaking of the C-O-C linkage and the 
fixation of one molecule of H2O. From the above spectroscopic data, the structure of compound 
1 was determined as a bis-acaridone, named, poggeicridone.  
It should be noted that poggeicridone is very unstable and easily decomposed, this may explain 
why only three dimers linked by C-O-C have been isolated from Tephrosia tepicana (Standl.) 
Standl. (Leguminosae) (Gomez-Garibay et al., 1997), from Swertia chirata Buch. Ham. 
(Gentianaceae) (Mandal and Chatterjee, 1987) and from Beilschmiedia zenkeri Engl. 
(Lauraceae) (Lenta et al., 2009). 
 
Compound 6 was obtained as a yellow amorphous powder. It gave a positive reaction with 
FeCl3, indicating its phenolic nature. The molecular composition was found to be C19H14N3O2 
by HR-EI-MS ([M]+ at m/z 315.1001, calcd 315.1004). The UV spectrum showed a highly 
conjugated system with absorption bands characteristic of indolopyridoquinazoline-type 
alkaloids (Ezugwu et al., 2003; Wansi et al., 2008). Its IR spectrum showed the presence of a 
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NH and a carbonyl at 3384 and 1656 cm-1, respectively. The 1H NMR spectrum (Table 2) of 
compound 6 exhibited four aromatic protons corresponding to an ortho-disubstituted ring A at 
δH 7.27 (t, J = 7.9 Hz, H-10), 7.47 (t, J = 8.2 Hz, H-11), 7.59 (d, J = 8.2 Hz, H-12), and 7.96 
(d, J = 7.9 Hz, H-9), together with three aromatic protons for an ABC system of ring E at δH 
6.98 (d, J = 1.3 Hz, H-1), 7.01 (dd, J = 8.3, 1.3 Hz, H-3), and 8.28 (d, J = 8.3 Hz, H-4) (Wansi 
et al., 2012). This inference was supported by the 13C NMR data (Table 2), which showed 
characteristic signals of an indoloquinazoline alkaloid of ring A at δC 120.7 (C-9), 121.0 (C-
10), 127.4 (C-11), and 112.5 (C-12), as well as for rings D and E at δC 105.1 (C-3), 116.0 (C-
1), 110.0 (C-4a), 129.2 (C-4), 141.0 (C-13b), 149.7 (C-14a), 158.5 (C-5), and 165.3 (C-2) 
(Wansi et al., 2012). Furthermore, the 1H NMR spectrum of compound 6 showed an AB system 
of two olefinic CH resonances at δH 7.50 (d, J = 7.6 Hz, H-8) and 8.65 (d, J = 7.6 Hz, H-7), 
and a methoxy group at δH 4.30 (brs). This assignment was furthermore supported by the 13C 
NMR spectrum, which showed additional two olefinic signals of C-7 and C-8 at δC 107.7 and 
118.3 respectively. The complete assignments of the indoloquinazoline skeleton and its 
substitution pattern were based on COSY, HMQC, and HMBC experiments. In the HMBC 
spectrum, correlations between the aromatic low-field signal of H-4 (δH 8.28) with C-5 (δC 
158.8) and C-2 (δC 165.3) and between proton H-1 (δH 6.98) with C-3 (δC 105.1), C-4a (δC 
110.0), C-14a (δC 149.7) and C-2 (δC 165.3) indicated the position of a methoxy group at C-2. 
From the above spectroscopic data, the structure of compound 6 was determined as 2-methoxy-
7,8-dehydroruteacarpine. 
 
Tests of pure compounds 2-9 on disc diffusion agar against bacteria (Bacillus subtilis, 
Staphylococcus aureus, Escherichia coli), fungi (Mucor miehei and Candida albicans), and 
plant pathogen oomycetes (Aphanomyces cochlioides, Pythium ultimum and Rhizoctonia solani) 
resulted in absent or low activities.  
As compounds 2-4 have previously been reported with oxidative burst inhibition and 
cytotoxicity properties (Happi et al., 2011), only compounds 5-9 were screened over a wide 
range of concentrations (3.1-50 μg·mL-1) for their immunomodulatory potential. These 
compound were shown to possess inhibitory activity upon activation with serum opsonized 
zymosan, which was tested in vitro for oxidative burst studies of whole blood. All compounds 
showed a strong suppressive effect on phagocyte oxidative burst of the whole blood in a dose-
dependent manner with IC50 ranging from 12.0 to 25.9 μM, compared to the control ibuprofen 
with IC50 = 11.2 μM (table 3). The results of the chemiluminescence assay suggest that 
compounds 5-9 represent effective naturally occurring molecules that prevent zymosan-
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induced oxidative burst with high efficiency. Further investigation could define 
pharmacological activities connected with oxidative stress, like inflammation and other 
pathologic conditions. In order to check whether the oxidative burst inhibition of those 
compounds is related to their cytotoxicity, we carry out cytotoxicity tests. Interestingly, those 
compounds (5-9) displayed moderate cytotoxic activity against the human Caucasian prostate 
adenocarcinoma cell PC-3 line with IC50 15.8 and 22.1 µM compared to standard doxorubicine 
with IC50 = 0.9 µM (table 4). 
The genus Zanthoxylum belong to the subfamily Rutoideae, tribe Zanthoxyleae (Takhtajan, 
2009), this subfamily rarely produces acridones alkaloids. To our knowledge, the acridones 
alkaloids were reported only in four species (Z. zanthoxyloides, Z. leprieuri, Z. macrophylla 
and Z. bungeanum) (Tringali et al., 2001; Wouatsa et al., 2013; Wang et al., 2014). Nonetheless 
several acridone alkaloids were isolated from the genera Ruta and Melicope belonging to the 
subfamily Rutoideae (Kuzovkina et al., 2004; Wang et al., 2014). Strong oxidative burst 
inhibition and moderate in vitro cytotoxic activity against the human Caucasian prostate 
adenocarcinoma cell line PC-3 of some constituents have been observed, which may contribute 
to the traditional use. 
 
3. Experimental 
3.1. General experimental procedures 
Ultraviolet spectra were recorded on a Hitachi UV 3200 spectrophotometer in MeOH. Infrared 
spectra were recorded on a JASCO 302-A spectrophotometer. ESI-HR mass spectra were 
recorded on a Bruker FTICR 4.7 T mass spectrometer. EI-MS were recorded on a Finnigan 
MAT 95 spectrometer (70 eV) with perfluorokerosene as reference substance for EI-HR-MS. 
The 1H- and 13C-NMR spectra were recorded at 500 MHz and 125 MHz respectively on Bruker 
DRX 500 NMR spectrometers. Methyl, methylene and methine carbons were distinguished by 
DEPT experiments. Homonuclear 1H connectivities were determined by using the COSY 
experiment. One-bond 1H-13C connectivities were determined with HMQC gradient pulse 
factor selection. Two- and three-bond 1H-13C connectivities were determined by HMBC 
experiments. Chemical shifts are reported in δ (ppm) using TMS as internal standard and 
coupling constants (J) were measured in Hz. Column chromatography was carried out on silica 
gel (70-230 mesh, Merck). TLC was performed on Merck precoated silica gel 60 F254 
aluminium foil, and spots were detected using ceric sulphate spray reagent. The purity of the 
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compounds was investigated by means of 1H-NMR and ESI-MS. The degree of purity of the 
positive control compounds was ≥ 98 %, while that of the isolated compounds was > 95 %. 
Doxorubicin was purchased from Sigma-Aldrich (Germany), nystatin was purchased from 
Maneesh Pharmaceutic Pvt. Ltd., Govandi, Mumbai 400043 (India) and gentamicin from 
Jinling Pharmaceutic (Group) corp., Zhejang Tieng Feng Pharmaceutic Factory, No. 11 
Chezhan Road, Huzhou city, Zhejang, China. The Caucasian prostate adenocarcinoma cell line 
PC-3 was purchased from the American Type Culture Collection (ATCC), 10801 University 
Blvd., Manassas, USA. All reagents used were of analytical grade. 
3.2. Plant material 
The fresh stem bark of Z. poggei were collected from Batouri, East region, Cameroon and 
identified by Mr Nana Victor of the National Herbarium, Yaoundé, Cameroon, where a 
voucher specimen was deposited under ref. 1970 SRF/CAM. 
3.3. Extraction and isolation 
The air-dried and powdered stem bark (1.5 kg) of Z. poggei was Soxhlet-extracted using DCM 
as a solvent. After evaporation under reduced pressure, 26.5 g of crude extract was obtained. 
This extract was purified by column chromatography over silica gel 60 (230-400 mesh, 6.5 × 
50 cm) and preparative TLC using a gradient system of n-hexane, CH2Cl2, ethyl acetate, and 
MeOH. A total of 95 sub-fractions (ca. 100 mL each) were collected and pooled on the basis 
of TLC analysis leading to four main series (A -D).  
Fraction A [6.5 g, combination of sub-fractions 1-28 (100–2700 mL), eluted with a mixture of 
n-hexane-DCM (3:1)] was chromatographed over silica gel 60C column (2.5 × 30.0 cm) with 
an n-hexane-DCM gradient. 18 sub-fractions of ca. 100 mL each were collected and combined 
based on TLC profiles. Sub-fractions 1-13 (100-1300 mL) were further chromatographed on 
silica gel 60H (2.5 × 30.0 cm) with a mixture of n-hexane-DCM (4:1) for elution to yield lupeol 
(15.5 mg).  
Fraction B [5.3 g, constituted by sub-fractions 29-50 (1000-2100 mL), eluted with a mixture 
of n-hexane-DCM (3:2)] was chromatographed over a silica gel 60C column (2.5 × 30.0 cm) 
with n-hexane-DCM gradient. 22 sub-fractions of ca. 100 mL each were collected and 
combined based on TLC comparison. Sub-fractions 1-10 (100-900 mL) were further 
chromatographed over silica gel 60H (2.5 × 30.0 cm) with a mixture of an n-hexane-CH2Cl2 
(3:1) to yield β-sitosterol (11.5 mg).  
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Fraction C [9.0 g, combination of sub-fractions 51-70 (100-1900 mL), eluted with n-hexane-
DCM (1:1) to 100% DCM] was chromatographed on a silica gel 60C column (2.5 × 30.0 cm) 
with an n-hexane-DCM gradient. A total of 32 fractions of ca. 100 mL each were collected and 
combined based on TLC. Sub-fractions 1-20 sub-fractions were chromatographed over silica 
gel 60H (2.5 × 30.0 cm) with a mixture of an n-hexane-DCM (1:1) and 100% DCM to yield 
Poggeicridone (1) (9.1 mg), citracridone I (2) (15.5 mg), and 2-methoxy-7,8- 
dehydroruteacarpine (6) (13.4 mg). Sub-fractions 21-32 sub-fractions were further 
chromatographed over silica gel 60H (2.5 × 30.0 cm) with 100% DCM to yield 5-
hydroxynoracronycine (4) (24.2 mg), 5-methoxynoracronycine (5) (5.5 mg) and 2-
methoxyruteacarpine (8) (16.5 mg). 
Similarly, fraction D [5.6 g, constituted by sub-fractions 71-95 (100-2400 mL), eluted with 
100% DCM and a mixture of DCM-MeOH (9.5:0.5) gradients] was chromatographed over 
silica gel 60C column (2.5 × 30.0 cm) with 100% DCM2 to gradients. As a result, 20 sub-
fractions of ca. 100 mL each were collected and combined on the basis of TLC to yield 
citracridone III (3) (6.6 mg), 2-hydroxyruteacarpine (7) (12.4), 5,8,13,14-tetrahydro-2-
methoxy-14-méthyl-5-oxo-7H-indolo[2’,3’:3,4]pyrido[2,1-b]quinazolin-6-ium chloride (9) 
(7.8). 
3.4. Poggeicridone (1) 
Yellow amorphous powder (Aceton); Rf = 0.50, silica gel 60 F254, DCM; UV (MeOH) 
max (log ) 260 (3.42), 290 (3.14), 335 (4.00), 345 (4.40) nm; IR (KBr) max 3100, 2950, 1639, 
1600, 1500, 1390, 1012, 750 cm1; 1H and 13C NMR data, see Table 1; EI-MS (%) m/z 363 
(C20H28NO5, 100), 347 (C19H23NO5, 76), 310 (36), 289 (25), 263 (14), 243 (20), 215 (15), 178 
(45), 149 (26); (+)-ESI-MS (%) m/z 681 ([M+Na]+, 100); HR-ESIMS [M+Na] + m/z 681.2209 
(calcd for C39H34O8N2Na, 681.2213).  
3.5.   2-methoxy-7,8-dehydroruteacarpine (6)  
Yellow amorphous powder (CHCl3-MeOH); Rf = 0.69, silica gel 60 F254, 
CH2Cl2/MeOH (9.5/0.5); UV (MeOH) max (log ) 210 (4.63), 282 (4.53), 290 (5.70), 326 
(4.54), 337 (4.45), 366 (4.60), 390 (4.50) nm; IR (KBr) max 3380, 3000, 2832, 1780, 1663, 
1656, 1595, 1390, 1217, 1015, 754 cm1; 1H and 13C NMR data, see Table 2; EI-MS (%) m/z 
315 ([M]+, 100), 297 (28), 257 (42), 242 (45), 228 (75), 156 (32), 199 (25), 173 (12), 68 (42); 
HR-EIMS [M] + m/z 315.1001 (calcd for C19H14N3O2, 315.1004). 
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3.6. Biological activities 
3.6.1. Paper disk agar diffusion assay 
Agar diffusion test plates with the bacteria B. subtilis and Escherichia coli (on peptone agar), 
S. aureus (Bacto nutrient agar) and the fungi M. miehei and C. albicans (Sabouraud agar) as 
test strains were performed as previously described (Maskey et al., 2002). For the plant 
pathogen oomycetes A. cochlioides, P. ultimum and R. solani, squares of 0.5 cm x 0.5 cm were 
cut with a microbiological hook from the growth margins of mycelial mats grown on PDA 
plates, inoculated onto the centers of fresh plates and cultivated for 24 h at 28 °C to initiate 
radial growth. Compounds 2–9 were dissolved in DCM/MeOH (9:1) and paper disks (Ø 9 mm) 
were impregnated with 40- mg each, dried for 1 h under sterile conditions and arranged evenly 
on the premade agar test plates, while for oomycete plates, the disks were placed around the 
mycelia squares at a distance of 30 mm. Bacteria and fungi plates were kept in an incubator at 
37 °C for 15 h, oomycetes at 28 °C for 48 h. The diameter of inhibition zones (mm) was 
measured directly or calculated from the radius. Nystatin was used as positive control for fungi 
and gentamycin for bacteria. B. subtilis, E. coli, S. aureus and C. albicans are clinical isolates 
received from the Center Pasteur du Cameroun, Yaounde, Cameroon and were carefully 
purified. Mucor miehei and the plant pathogen oomycetes Aphanomyces cochlioides, Pythium 
ultimum, and Rhizoctonia solani originate from the Institute of Organic and Biomolecular 
Chemistry, Georg-August University Göttingen. 
 
3.6.2. Microdilution broth assay  
The MICs of compound were measured by the microdilution broth susceptibility assay 
(CLSI/NCCLS, 2008). The inocula of bacterial and fungal strains were prepared from 12 h 
broth cultures, and suspensions were adjusted to 0.5 McFarland standard turbidity. The 
compounds were dissolved in 10% DMSO and serial twofold diluted in 96-well microtiter 
plates in duplicate, using BHI broth for bacterial and Sabouraud dextrose broth for fungal tests. 
Standardized inocula of test strains were added and incubated at 37 °C for 24 h on a rotary 
shaker at 200 rpm. The MIC is read as the lowest concentration that inhibits test strain growth. 
 
3.6.3. Chemiluminescence assay for determination of immunomodulatory activity:  
A luminol-enhanced chemiluminescence assay was performed as previously described 
(Helfand et al., 1982). Whole blood (diluted 1:200) and neutrophils (1 × 107) suspended in 
Hankʼs balance salt solution with calcium and magnesium (HBSS++) were incubated with 50 
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μL of each test compound at concentrations of 3.1-50 μg.mL−1 for 30 min. To each well, 50 μL 
(20 mg.mL−1) of zymosan (Sigma Chemical Co.), 50 μL (7 × 105 M) of luminol (G-9382; 
Sigma Chemical Co.), and then HBSS++ were added to adjust the final volume to 0.2 ml. 
HBSS++ was used as a control. Luminescence peaks are recorded with a luminometer 
(Luminoskan RS Lab system) and expressed as median inhibitory concentrations (IC50) ± 
standard error of mean, with ibuprofen as the standard (IC50 = 11.2 ± 1.8 μM). 
3.6.4. Cytotoxicity assay 
Cytotoxic activities of the compound were evaluated against the human Caucasian prostate 
adenocarcinoma cell line PC3 by the MTT method as reported by Zhao et al., (2008). Freshly 
trypsinized cell suspensions were seeded into 96-well microtiter plates at densities of 1 × 104 
cells per well, and test compounds were added from DMSO-diluted stock. After 3 days, the 
attached cells were incubated with MTT and subsequently solubilized in DMSO. The 
absorbance at 550 nm was measured by using a microplate reader. The IC50 is the concentration 
of agent that reduced cell growth under experimental conditions by 50%, with Doxorubicin as 
the positive control (IC50 = 0.9 μM).  
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Table 1. 1H (500 MHz) and 13C (125 MHz) NMR assignments for (1) in Aceton-d6 at 15°C
a 
Attribution 1 
13C 1H [m, J (Hz)] 
1 164.6 14.51 (s) 
2 97.5 6.13 (s) 
3 161.2 - 
4 102.5 - 
4a 147.6 - 
5 137.1 - 
6 156.1 - 
7 113.0 7.01 (d, 8.8) 
8 122.2 7.97 (d, 8.8) 
8a 119.9 - 
9 181.3 - 
9a 106.8 - 
10a 142.6 - 
11 122.3 6.76 (d, 9.7) 
12 124.9 5.70 (d, 9.7) 
13 76.5 - 
14 28.5 1.52 (s) 
15 26.5 1.47 (s) 
N-CH3 48.2 3.80 (s) 
O-CH3 59.6 3.92 (s) 
1’ 163.9 14.44 (s) 
2’ 97.2 6.12 (s) 
3’ 160.9 - 
4’ 102.3 - 
4a’ 147.9 - 
5’ 148.3 - 
6’ 120.6 7.33 (d, 7.5) 
7’’ 124.3 7.24 (dd, 7.8 ; 7.5) 
8’ 117.6 7.83 (dd, 7.5; 1.5) 
8a’ 124.9 - 
9’ 181.9 - 
9a’ 106.5 - 
10a’ 147.9 - 
11’ 122.3 6.74 (d, 9.7) 
12’ 123.9 5.68 (d, 9.7) 
13’ 76.5 - 
14’ 28.5 1.51 (s) 
15’ 26.4 1.48 (s) 
N-CH3 48.1 3.86 (s) 
           aAssignments were based on HMQC, HMBC, COSY and  NOESY experiment 
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Table 2. 1H (500 MHz) and 13C (125 MHz) NMR assignments for (6) in CDCl3/MeOD
a 
Attribution 6 
 13C 1H [m, J (Hz)] 
1 116.0 6.98 (d, J = 1.3) 
2 165.3 - 
3 105.1 7. 01 (dd, J = 8.3; 1.3) 
4 129.2 8.28 (d, J = 8.3) 
4a 110.0 - 
5 158.8 - 
7 118.3 8.65 (d, J = 7.6) 
8 107.7 7.50 (d, J = 7.6) 
8a 121.7 - 
9a 123.7 - 
9 120.7 7.96 (d, J = 7.9) 
10 121.0 7.27 (t, J = 7.9) 
11 127.4 7.47 (t, J = 8.2) 
12 112.5 7.59 (d, J = 8.2) 
12a 139.8 - 
13a 129.3 - 
13b 141.7 - 
14a 149.7 - 
OMe 55.5 4.30 (s) 
aAssignments were based on HMQC, HMBC, COSY and  NOESY experiment 
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Table 3. Effect of compounds 5-9 on oxidative burst of whole blood. 
Compounds IC50 ± S.E.M.(µM) 
5 13.5 ± 3.5 
6 21.6 ± 2.5 
7 24.5 ± 3.6 
8 25.9 ± 1.5 
9 12.5 ± 0.4 
Ibuprofena  0.9 ± 0.1 
astandard used in the assay 
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Table 4. Cytotoxicity against human prostate adenocarcinoma cell line PC-3. 
Compounds IC50 ± S.E.M.(µM) 
5 16.5 ± 1.4 
6 22.1 ± 2.5 
7 17.4 ± 2.0 
8 19.6 ± 3.0 
9 15.8 ± 1.5 
doxorubicina  0.9 ± 0.1 
astandard used in the assay 
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Figure 1 Structures of compounds 1-9. 
 
 
 
 
